← Eichor
Study identifier: NCT04711551 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics

Condition: Musculoskeletal System Disease  ·  Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

PhaseN/A
Planned participants2000
Who can joinAll sexes, 6 Years to no upper limit
Healthy volunteersNo

About this study

the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study. patients who undergo regenerative medicine treatments present acute and chronic pathologies of the musculoskeletal system, of the stomatological system and of the integuments. Objective pre, peri and post treatment evaluations are collected. A dedicated software collects the PROMs compiled by the patients, the objective clinical data and the biomolecular evaluations.

This description comes directly from the study's public registry record.

Talk to the study team

Laura De Girolamo  ·  0039 0283502221  ·  laura.degirolamo@grupposandonato.it

Always discuss trial participation with your own doctor first.

Locations (2)

Istituto Clinico San Siro (satellite center)Milan, Italia, ItalyRecruiting
IRCCS Ospedale Galeazzi-Sant'Ambrogio (coordinator)Milan, Italy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04711551